Atlas Trials

Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer

Clinical trial NCT01589367 · COMPLETED

Trial details

NCT number
NCT01589367
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hormone Receptor Positive Malignant Neoplasm of Breast
Start date
2012-05-01
Primary completion
2018-04-01
Enrollment
208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.